Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LAMIVUDINE Oral Solution, USP safely and effectively. See full prescribing information for LAMIVUDINE Oral Solution, USP LAMIVUDINE Oral Solution, USP for oral use Initial U.S. Approval: 1995
Medication labelWhy this: Advisory · dailymed-prescription
Lamivudine Oral Solution, USP is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection. Limitation of use: The dosage of this product is for HIV-1 and not for HBV.
- generic_name
- lamivudine
- product_names
- Lamivudine
- ndc
- 10135-605, 10135-605-71
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en